Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Omitting axillary dissection after negative sentinel node biopsy is not contraindicated
April 11th, 2006
Concerns that omitting completion axillary dissection following a negative sentinel lymph node biopsy will increase the rate of axillary recurrence appear unfounded. According to scientists at the Roswell Park Cancer Institute in Buffalo, "Sentinel lymph node biopsy (SLNB) is widely used for staging breast cancer. SLNB accurately determines axillary lymph node status with a low false negative rate. There remains concern that omitting axillary dissection may lead to recurrence in the axilla, and impact long term survival. The purpose of this study was to determine the frequency of axillary lymph node recurrence in patients who had a negative sentinel lymph node and did...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
